Forging a path for MedTech Innovation.
Device recalls have inherently been, and still are, a largely manual process, with manufacturers working from spreadsheets and Commercial teams visiting consignee locations to obtain responses from affected consignees. With over 16 000 device Recalls in 2024 affecting more than 70 million devices worldwide, recalls have garnered more scrutiny and media attention in today’s consumer driven environment, notwithstanding regulatory body pressure.
The burden placed on existing service & commercial teams to execute a recall could mean loss in potential revenue and placing patient safety at risk. Additionally, with the recent advancements made in digital health and increasing pressures on MedTech supply chains globally, organisations face huge challenges in ensuring the safety & quality of their products.
So, what is a recall? A device recall typically occurs when an organisation is either mandated to or voluntarily withdraws a potentially harmful product from the market to protect patients and maintain brand integrity. A manufacturer can also recall a product for commercial purposes i.e. swopping out existing products in market for a new product with updated technology or a device has been manufactured using new and/or updated material.
In this blog post, we’ll explore the need for digital intervention and how this can mitigate for a poorly executed product Recall.
To support the need for digital tools and demonstrate their clear value, recent data from product recalls executed by IQVIA MedTech globally indicate an emerging trend and favourability in using digital tools when responding to or acknowledging a FSN or recall. Some data from recent projects (averaged) that can be attributed to this are as follows:
These data points reflect a clear shift & adoption towards and preference for, digital engagement channels- 84% out of 94% consignees responded to FSN’s or recall notifications by using the digital channel. It must also be stated that consignees are offered all the traditional channels to respond via, including mail, email & voice. But the evidence and data are clear- digital channels are quicker, more user friendly and effective in obtaining responses from consignees.
By investing in digital tools and leveraging them to positively affect your device recall and ultimately save patients’ lives, MedTech manufacturers can improve the efficiency and effectiveness of their device recall processes. Additionally, this demonstrates an organizations commitment to patient safety & helps preserve brand reputation. By being transparent & striving for quality excellence, MedTech organizations can ensure that their products consistently meet the safety standards of regulators & by doing so, maintain patient, carer & HCP trust & loyalty.
Click the CONTACT US button to speak to the IQVIA MedTech team about your MedTech recall strategy.
Forging a path for MedTech Innovation.
Connected commercial solutions, maximizing market performance.